Results 131 to 140 of about 2,514 (185)

Synergistic adverse prognostic impact of CD30 and Epstein-Barr virus in peripheral T-cell lymphoma: CD30 identifies a high-risk subgroup in Epstein-Barr virus-encoded RNA -positive patients. [PDF]

Ann Hematol
Chen ZT, Huang L, Zhang XD, Wang N, Jiang XM, Wei XJ, Zhang H, Guo HG, Lin CD, Chen FL, Liu SC, Liang ZL, Li WY.   +12 more
europepmc   +1 more source

Eosinophilic dermatosis of hematologic malignancy associated with angioimmunoblastic T-cell lymphoma. [PDF]

JAAD Case Rep
Harris JB, Samia AM, Sun CW, Motaparthi K.   +3 more
europepmc   +1 more source

Impact of <i>KMT2A</i> Rearrangement on Peripheral T-Cell Lymphoma, Not Otherwise Specified, and Angioimmunoblastic T-Cell Lymphoma. [PDF]

Biomedicines
Kim TY, Kim TJ, Han EJ, Min GJ, Cho SG, Jeon Y.   +5 more
europepmc   +1 more source

Epstein-barr virus-encoded small RNA incorporated prognostic model enables precision risk stratification and guides treatment decisions in peripheral t-cell lymphoma: a multicenter retrospective cohort. [PDF]

Ann Hematol
Chen ZT, Huang L, Guo HG, Lin CD, Jiang XM, Wei XJ, Chen FL, Liu SC, Zhang H, Liang ZL, Wang N, Zhang XD, Lin LE, Liu TB, Zhou JH, Peng ZG, Li WY.   +16 more
europepmc   +1 more source

Late-onset cytomegalovirus pneumonia after autologous stem cell transplantation for angioimmunoblastic T-cell lymphoma: a case report. [PDF]

Ther Adv Infect Dis
Zhang Z, Jia Z, Zhang X, Zou W, Chen J.
europepmc   +1 more source

Integrating genomic and transcriptome features for characterization and prognostic prediction of angioimmunoblastic T-cell lymphoma. [PDF]

Ann Hematol
Wei C, Jia C, Zhang Y, Zhao D, Zhang W, Zhou D.   +5 more
europepmc   +1 more source

A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma. [PDF]

Blood Adv
Gordon MJ, Miljkovic MD, Milhon P, Lakhotia R, Melani C, Johnson K, Bryant B, Pittaluga S, Jaffe ES, Conlon K, Staudt LM, Wilson WH, Roschewski M, Ng S.   +13 more
europepmc   +1 more source

Care Patterns, Outcomes, and Costs in Peripheral T-Cell Lymphoma Patients with First-Line Treatment in Routine Clinical Practice in Europe. [PDF]

J Blood Med
Kristo F, Kelkar SS, Raina R, Schmier JK, Dalal MR, Ashaye AO.   +5 more
europepmc   +1 more source

Pioneering the future: nanotechnology's role in angioimmunoblastic T-cell lymphoma. [PDF]

Ann Med Surg (Lond)
Anjum HM, Ahmad J, Talha M, Shamim L, Imran SB.   +4 more
europepmc   +1 more source

Revisiting the Origins of Cutaneous T-Cell Lymphoma: A Progenitor-Based Model. [PDF]

Cancers (Basel)
Zhang Y, Sokol L.
europepmc   +1 more source